If Nader really and truly cared about success and share value, he would step aside as the public-facing person of this company. He can do all his wheeling and dealing and whatever else he may be good at... But there is zero comms strategy. None. Combine that with an XL ego. He's learned nothing over the past year and still runs things into the ground with an iron fist. CD12 news could've been spun so differently and we could be sitting easily on a $6 or $7 SP now.

I wish he'd hire a company President to lead D2D and comms and step away from the limelight.

Puppies are easier to train than NP will ever be.

Quote:

---

“Sell and move on” to that end a number of investors have written letters to management...

Dear Dr.’s Pourhassan and Kelly,

I am an investor originally through Paulson in 2015. My entry point was .75 with warrants. At one point I held over $1,000,000.00 in CYDY. Although there has been unquestionably a monumental effort coming from management with regard to person hours and intensity, in my opinion execution has been unsuccessful and certainly NOT something to “celebrate”. Although I personally have profited when I recently sold at least two thirds of my shares (I believe both of you sold quite a few shares as well) people I know that invested later are suffering. I believe you eat when your troops eat.

Without getting to granular I think the HIV BLA is a disaster. I also suspect your interactions with the FDA and NIH were not handled in an entirely professional manor. Your cutting of ties with Dr. Bruce Patterson...strike three. This can not be a learn as you go c suite. There is no shame in admitting this and taking appropriate action in terms of partnering with a larger pharma company or simply stepping down and finding someone that is more experienced with navigating the Kafka esque landscape of American pharma. The shame is not doing what is in the best interest of Cytodyn and your investors. I am on the verge of selling the rest of my shares and advising the investors that came in after me to do the same.

---